Mumps in Patients with Acute Encephalitis Syndrome in Assam, India during January 2018 to July 2021

Kimmi Sarmah1, Kishore Sarma2, Prasanta Kumar Borah3

  • 1Scientist B (Non-Medical), State Level VRDL, Department of Virology, Gauhati Medical College and Hospital, Guwahati, Assam, India.

PubMed

Insights

Mumps virus (MuV) causes acute encephalitis syndrome (AES) in Assam, India. This study found MuV in 22% of AES cases, highlighting its significant role and potential for treatment.

Area of Science:

  • Virology
  • Neurology
  • Public Health

Background:

  • Acute encephalitis syndrome (AES) is a global health concern with diverse etiologies, primarily viral.
  • The viral causes of AES in Assam, India, remain under-investigated.
  • Encephalitis caused by mumps virus (MuV) is treatable, unlike many other viral AES causes.

Purpose of the Study:

  • To determine the prevalence of mumps virus (MuV) positivity in patients with acute encephalitis syndrome (AES).
  • To characterize MuV genotypes circulating in AES cases in Assam, India.
  • To assess the temporal trends of MuV as an AES etiology compared to Japanese encephalitis (JE).

Main Methods:

  • Enzyme immunoassay (EIA) was used to detect MuV immunoglobulin M (IgM) antibodies in 317 cerebrospinal fluid and serum samples.
  • Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) was performed on positive samples.
  • MuV-positive cases were genotyped targeting the small hydrophobic (SH) gene.

Main Results:

  • MuV IgM antibodies were detected in 22.0% (70/317) of AES cases.
  • Higher MuV prevalence was observed in males, with a peak incidence in July.
  • Genotyping revealed the circulation of mumps virus genotypes C and G during the study period (January 2018–July 2021).

Conclusions:

  • Mumps virus (MuV) is a significant etiological agent of acute encephalitis syndrome (AES) in Assam, India.
  • The study indicates an increasing emergence of MuV over Japanese encephalitis (JE) as a cause of AES in the region.
  • Timely diagnosis and treatment of MuV-associated encephalitis are crucial for patient outcomes.